This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
spk06: Good morning. Welcome to the WTW Third Quarter 2024 earnings conference call. Please refer to WTWCO.com for the press release and supplemental information that were issued earlier today. Today's call is being recorded and will be available for the next three months on WTW's website. Some of the comments in today's call may constitute forward looking statements within the meaning of the Private Securities Reform Act of 1995. These forward looking statements are subject to risks and uncertainties. Actual results may differ materially from those discussed today and the company undertakes no obligation to update these statements unless required by law. For a more detailed discussion of these and other risk factors, investors should review the forward looking statement section of the earnings press release issued this morning, as well as other disclosures in the company's most recent Form 10-K and other filings the company has made with the SEC. During the call, certain non-GAAP financial measures will be discussed. For reconciliations of the non-GAAP measures, as well as other information regarding these measures, please refer to the earnings press release issued this morning and other materials in the investor relations section of the company's website. I'll now turn the call over to Carl Hess, WTW's Chief Executive Officer.
spk05: Please go ahead.
spk13: Good morning, everyone. Thank you for joining us for
spk02: WTW's third quarter 2024 earnings call. Joining me today is Andrew Krasner, our Chief Financial Officer. We had another strong quarter, delivering 6% organic revenue growth, driven by 10% organic growth in risk and broking and 4% in HWC. Adjusted operating margin expanded 190 basis points year over year to 18.1%, driven by operating leverage, continued cost discipline, and the success of our transformation program. Taken together, this resulted in adjusted diluted earnings per share of $2.93, a 31% increase versus the third quarter of 2023. We also generated free cash flow of $807 million for the nine months ended September 30th, up 14% year over year. While our GAAP results reflect the loss due to the accounting treatment of the pending sale of our transact business, which Andrew will discuss in more detail, our strong third quarter operating performance gave us momentum as we entered the fourth quarter. Our value proposition and powerful solutions continue to resonate in the marketplace, and our investments in talent and technology are helping fuel our continued strong performance and attractive returns. Alongside the supportive demand environment we're experiencing, these factors make us confident we will deliver on our 2024 targets. And more specifically within those targets, as we mentioned last quarter, we do see some opportunities for stronger performance relative to our margin goals. Potential upside could come from better than expected productivity for investment in talent, the timing of transformation savings, continued expense management, and the possibility of rebounding global M&A activity. Now let me share some details on our performance and developments this quarter that highlight our strategic progress. In HWC, we achieved organic growth of 4% in the quarter, even as we continue to intentionally moderate growth in our transact business. While employment and wage growth slowed somewhat in various parts of the world, demand remained strong. Our HWC capitalized on this and grew 6% in health, 3% in wealth, and 7% in career. Core growth and smart connections remained our focus, resulting in continued growth in global benefits management, compensation benchmarking surveys, de-risking activity, and total awards assignments. We've also gained notable new appointments for benefits outsourcing, remuneration committee advisory services, our retiree health care exchange, and core actuarial services. These wins will add more than 50,000 new customers to our individual health care exchange from the state of Maryland, and they include us being named actuary to a major US utility through a competitive bidding process where we unseated the 30-year incumbent. Continuing our track record of introducing breakthrough solutions that lead the market, we introduced several new solutions again this quarter. We designed a virtual captive to affect cost and risk mitigation strategies for employee benefits in more than 80 countries that can't be covered in a traditional captive insurance company. Our approach incorporates data aggregation and predictive analytics. We also developed a new workforce management proposition, an -to-end solution to help organizations manage reductions in force. The proposition includes predictive modeling capabilities to achieve cost reduction targets while minimizing cash flow impacts and limiting the risk of unwanted turnover. It also includes effective change in communication management to support the organization's culture and sustain employee engagement. Our focus on smart connections across HWC has also continued to pay dividends, as it did when we provided cross-business services to a gas company that was concerned about cost savings. Colleagues across work and rewards, retirement, BDA, and employee experience engaged with the company's HR and finance teams to design and support a workforce separation program, move their retirees to our individual marketplace, and transfer some of their retiree medical and life obligations to an insurance carrier. In another example, CRB recognized that a European technology client going through an acquisition needed help with corporate risk and employee benefits, and so they introduced HWC. Together, the WTW team supported due diligence, strategic planning, and the integration of employee benefits and corporate brokerage services. Risk and broking continue to grow at pace this quarter, delivering 10% organic growth on top of 10% growth in the prior year period. Our specialization strategy, investments in talented technology, strong client retention rates, and substantial new business generation all contributed to this excellent performance. Our specialty businesses continue to generate the strongest growth in the segment. Our focus on specialization has enabled us to better address our clients' complicated and ever-changing risk profiles and continues to be a primary driver of our strong organic growth. We also continue to make progress on our strategy to rapidly expand our MGA, MGU, data and analytics, affinity, and specialty solutions by developing innovative products and services with strategic partners. Let me update you on the latest developments. First, Verita, our open market MGU in North America, has exceeded our growth expectations since its launch at the beginning of the year. To bolster our offering, Verita recently partnered with Canopius US Insurance to introduce a new option called the Client Edge Facility, which will efficiently deliver additional needed property insurance capacity for large and complex risks as well as middle market risks. This new venture reflects Verita's focus on bringing new innovative insurance solutions to clients, brokers, and capacity partners. Second, we announced a partnership with Canop, a top-tier insurance infrastructure platform. This collaboration will enable us to bring our data and analytics tools and insurance advisory and brokerage expertise to the fast-growing affinity insurance sector and meaningfully strengthen our presence there. Together with Cata, we're offering administration for industry specialized platforms to distribute tailored property, general liability, workers' compensation, commercial auto and umbrella liability insurance solutions to a variety of sectors. Our specialist teams will lead the product development and broker all insurance offerings. The third strategic partnership that our R&B segment announced this quarter was our co-brokerage agreement with the J. Mori Company, which will focus on North American exposures of companies headquartered in Japan. Asian companies with unique risk management needs will now have access to WTW's vast carrier relationships and our specialty insurance skill set, which will help them tailor solutions to address industry and geography specific risks. These strategic partnerships complement and strengthen our focus on specialization and expansion to high margin parts of the insurance value chain, which have been driving and will continue to drive margin to create organic growth in R&B. Moving from growth to margins, both operating leverage and our transformation efforts were key contributors to margin expansion during the quarter. The transformation program realized $52 million of incremental annualized savings this quarter, bringing the total to $446 million in cumulative annualized savings since the program's inception. In addition to the direct margin impact transformation is made, the investments we've made in technology, processes and infrastructure across the life of the program have better positioned us to drive further efficiencies and continued operating leverage well into the future. Finally, I want to update you on our portfolio management activities. Portfolio management has been a part of our strategy over the last three years as we work to simplify our organization and focus on businesses with significant growth opportunities and strong margin and cash flow profiles that also align to our core capabilities. As announced earlier this month, we entered into a definitive agreement to sell Transact. Transact was WTW's only direct to consumer business and this sale significantly simplifies our portfolio and our strategy by enabling us to focus on our core B2B and B2B to C activities. Notably, divesting Transact also accelerates our progress toward our long term free cash flow margin expansion goals. Andrew is going to walk through the financial and accounting details of the sale later. Elsewhere in our portfolio, we acquired a minority interest stake in Atomos, a UK based wealth manager, which strengthens the existing strategic alliance between our wealth business and Atomos. Atomos uses WTW's investment engine to provide its clients who are individual investors with a broad and diverse array of investment options that were previously only available to institutional investors. This expanded relationship with Atomos will allow WTW to penetrate the large and growing UK wealth market, which has an estimated market value of 2.2 trillion pounds. These strategic portfolio management actions, along with the partnership announcement I mentioned earlier, reflect our continued focus on reviewing our portfolio to ensure our businesses are well aligned and strongly positioned to drive profitable growth. This dovetails with our disciplined capital allocation process through which we consider all our options to maximize shareholder value creation, including share repurchases, internal investments, and carefully considered strategic M&A. In closing, we're pleased with our third quarter performance, which reflects our team's focus and hard work to meet our clients' needs with innovative ideas and efficiency. As we enter the fourth quarter, we're focused on executing on our strategic priorities. I'm encouraged and excited by the enthusiastic client response and the opportunities we see in the market. We have positive momentum and I'm confident we'll finish the year strong and achieve our objectives. And with that, I'll turn the call over to Andrew.
spk15: Thanks, Carl. Good morning and thanks for joining us today. In the third quarter, we delivered organic revenue growth of 6%. Adjusted operating margin expanded 190 basis points to .1% and adjusted diluted earnings per share were $2.93, an increase of 31% over the prior year. Our solid results continue to give us confidence in achieving our 2024 financial targets. Next, I'll spend some time reviewing our segment results. Note that to provide comparability with prior periods, all commentary regarding the results of our segments will be on an organic basis unless specifically stated otherwise. Health, wealth, and career revenue grew 4% compared to the third quarter of last year. Our health business generated revenue growth of 6% for the quarter or 5% excluding Book of Business activity. Double-digit growth in international, along with strong growth in Europe, was driven by solid client retention, new local appointments, and the continued expansion of our global benefits management client portfolio. North America generated growth as a result of increased brokerage income. We continue to expect high single-digit growth for the business for the year based on our pipeline and our expected commission stream. Wealth revenue grew 3% in the third quarter driven by strong growth in our retirement business, primarily due to valuation work in Europe. We also delivered solid growth in our investments business due to improvements in capital markets and growth from our life-site solution. Career delivered 7% growth for the quarter. Growth in compensation benchmarking participation helped deliver increased compensation survey sales and custom data analytics and working rewards. In employee experience, we saw growth in our sales of our onboard portal. Benefits delivery and outsourcing had a decline of 1% versus the third quarter of last year. As a reminder, BD&O faced a strong comparable this quarter due to the timing of project work and outsourcing during last year's third quarter, as well as a headwind related to a previously mentioned client who insourced its health and other benefits administration. And as we discussed last quarter, we have been deliberately moderating growth in our Medicare related businesses. As a result for the year, we are expecting BD&O to have low single-digit growth with and without TransAct. HWC's operating margin was 24.7%, an increase of 90 basis points compared to the prior year third quarter, primarily driven by transformation savings. Moving to risk and broking, third quarter revenue was up 10% on an organic basis and operating margin expanded 240 basis points to 18.1%. This includes book of business activity of $4 million versus $1 million in the prior year. Interest income was up $4 million from the third quarter last year. Corporate risk and broking had a solid quarter, growing 10% with strong contributions across all geographies, including double-digit growth in Great Britain and our Western Europe and international regions. As Carl mentioned, our special C lines continue to be major contributors to the strong growth performance, led globally by our facultative, crisis management, and financial solutions businesses. We also saw very strong performance by two of our largest specialty businesses, FinEx and Construction. Growth in CRB Great Britain was led by facultative, financial solutions, crisis management, FinEx, Construction, and aerospace. Across CRB Western Europe, we saw strong growth in our FinEx and natural resources businesses. Western Europe also had double-digit growth in a number of our countries in the region. North America CRB had solid growth supported by strong contributions from our construction, marine, and natural resource businesses. Our international region had organic growth across all subregions, led by double-digit growth in Latin America and Asia, and double-digit growth in almost all of our specialty businesses, as well as P&C retail and affinity. We continue to see the stabilizing and softening of global rates from the slowdown in the US inflation. Property, financial lines, and commercial rates are decreasing. Casualty remains stable, but market conditions are increasingly difficult for motor risks and North American exposures. Hurricane Milton did not seem to increase natural catastrophe rates, but its financial impact is still uncertain. Our specialty lines continue to stabilize, but with some increases in political risks and trade credit. Moving on to our insurance consulting and technology business, revenue is up 7% with strong double-digit growth in our technology practice, partially offset by continued tempered demand in the consulting practices. R&B's operating margin was .1% for the quarter, a 240 basis point increase over the prior year third quarter, primarily due to operating leverage driven by organic revenue growth and disciplined expense management, as well as transformation savings. We continue to expect margin expansion for R&B for the full year, but as a reminder, in Q4, we will face headwinds from $14 million of book of business activity that occurred in Q4 of last year. Now let's turn to the enterprise level results. At the enterprise level, adjusted operating margin for the quarter was 18.1%, a 190 basis point increase over prior year, primarily driven by operating leverage and the benefits of our transformation program. We had 52 million of incremental annualized transformation savings, bringing the total to 446 million of cumulative savings since the program's inception. Our unallocated net was negative 85 million for the third quarter. We continue to expect the full year 2024 balance to be relatively consistent with 2023. Foreign exchange was a headwind to adjusted EPS of two cents for the quarter. At current spot rates, we expect foreign exchange to be a headwind of approximately six cents on adjusted EPS for the year. Our US GAAP tax rate for the quarter was .1% versus .5% in the prior year. Our adjusted tax rate for the quarter was .7% compared to .3% for the third quarter of 2023. We previously mentioned that we anticipated our adjusted tax rate for the year to be similar to our 2023 rate, excluding last year's one-time tax items, which was 22.4%. Given our current position, we now expect our adjusted tax rate to be moderately more favorable. During the quarter, we returned 294 million to our shareholders via share repurchases of 205 million and dividends of 89 million. We continue to view share repurchases as an attractive use of capital to create long-term shareholder value and the central focus of our balanced approach to capital allocation. As we mentioned previously, we continuously monitor our cash levels and market conditions to take advantage of opportunities to accelerate repurchases if the opportunity presents itself. With that, based on current market conditions and other relevant factors, we now expect share repurchases for the year to be 900 million, up from our previous estimate of 750 million. As Carl mentioned, WTW has entered a definitive agreement to sell the TransAct business. We believe this sale will help us sharpen our strategic focus, simplify our portfolio, and accelerate our progress towards our long-term free cash flow margin goals. In connection with the pending transaction, held for sale accounting treatment applies to TransAct assets and liabilities. The financial results of TransAct will continue to be reflected in our financial statement through the closing date of the transaction, which is expected to be later in Q4, subject to regulatory approvals and customary closing conditions. We do not expect the transaction to impact our financial targets for the year, as we anticipate booking approximately a full year of financial results for TransAct. The pending transaction resulted in pre-tax losses and related impairment charges of over $1 billion each, which are reflected in the gap results for Q3. These are one-time, non-cash charges and are not included in adjusted diluted earnings per share. TransAct's standalone historical financial results are included in the supplemental slides. While I won't review those in detail now, I do want to highlight that we expect the sale to be accretive to organic growth, adjusted operating margins, and free cash flow margin. We generated free cash flow of $807 million for the nine months ended September 30, an increase of $100 million from the prior year, primarily driven by operating margin expansion, partially offset by cash outflows related to transformation and discretionary compensation payments. We continue to be confident in our expectations of -over-year improvement in full year free cash flow margin. And given the sale of TransAct, we expect to accelerate our progress towards our long-term free cash flow margin goal. In closing, we are very pleased with our strong business performance and expect this momentum to enable us to achieve our 2024 targets. With that, let's open it up for Q&A.
spk06: Thank you. At this time, we will conduct the question and answer session. As a reminder, to ask a question, you will need to press star 1-1 on your telephone and wait for your name to be announced. To withdraw your question, please press star 1-1 again. We will allow one question and one follow-up per participant. Please stand by while we compile the
spk05: Q&A roster. Our first question comes from Greg Peters of Raymond
spk06: James. Your line is now open.
spk11: Hey, this is Mitch Rubin on behalf of Greg Peters. Thanks for taking my question. Can you clarify the impact of the sale of TransAct on Q3 organic results and free cash flow?
spk15: Morning, Mitch. Thanks for your question. In Q3, TransAct was a 70 basis point headwind on organic growth at the HWC level and 50 basis points at the enterprise level. It's important to note that BDO's results were unevened in the second half of the prior year with 14% growth in Q3 and 3% growth in Q4. So the full year results will serve as more of a relevant comparison point for that specific business unit. For 2025, we anticipate that excluding TransAct from our results will have a positive impact on our organic growth adjusted operating margin and the free cash flow margin profile.
spk11: Thank you. As a follow-up, can you provide some additional color on the impact of new hires and growth and exposure units on organic growth inside risk and broken? Thanks.
spk02: Sure,
spk11: Mitch. This is Carl.
spk02: Let me give you some perspective there. When you look at the growth, and we're really happy with the growth that we enjoyed in risk and broken for the quarter, the principal drivers to that were client retention and new business. And we didn't actually have much of an effect as in prior quarters from rate. And our new hires were really pleased with the progress they've made, are part of that growth story, but they're only part. Right. The majority of our growth is due to all our colleagues, including the new hires.
spk06: Thank you. Our next question comes from Elise Greenspan of Wells Fargo. Your line is now open.
spk09: Hi, thanks. Good morning. So my first question, Carl, you started off by saying you were positive there's a tailwind to this year's margin guide. Andrew, you lowered the tax guidance and upped the buyback guidance, but you guys have not changed the EPS guidance for the year. Is there some conservatism built in? Do you expect to be at the high end of the range? How do we think about these positive updates relative to the lack of changing the overall 2024 EPS guide?
spk02: So let me talk a little bit about margin guidance, Elise, and then Andrew can follow up on EPS. We had 190 basis points of margin expansion this quarter. That's 210 basis points of expansion year to date. We're really pleased with our execution. We remain optimistic with where we're tracking within the margin guidance range. But we do continue to see opportunities for stronger performance relative to that guidance, for example, better than expected productivity from our investment and talent in both segments, including with the R&Bs, as I was just talking about with Mitch. The timing of transformation savings, we're continuing to find opportunities to trim expenses without impacting growth and productivity. And, you know, there's the potential for rebounding global M&A activity that creates opportunities within both segments.
spk15: And all of those factors, Carl, could lead to outperformance on the margin side. And it's also important to keep in mind that there was a $14 million book of business sale that happened in Q4 of last year. So that would be a headwind as well as, you know, the pacing and of transformation savings that really came through in the fourth quarter last year that also produced a bit of a tougher comparable. In terms of EPS, Elise, we're pleased with our execution year to date and last quarter raised the low end of our EPS target range. And, you know, given the momentum we see in the business and our ability to execute, we're confident that we'll deliver EPS within that range. You know, in terms of, you know, any opportunity to outperform there, that's really going to start with the outperformance on the adjusted operating margin that Carl just alluded to, you know, coupled with greater top line growth.
spk09: Thanks. And then my follow up, you know, was on repurchase. I appreciate, right, that you guys did up, you know, this year's guidance by $150 million. But you guys are coming into a good amount of cash next year. We have, you know, the earn out from, you know, Gallaghery 750, right? Something in the range, $650 million from the France Mass divestiture. So, you know, when you think about all this cash coming in store, Carl, I think you said balanced approach to M&A. So I'm just trying to think about how you're going to balance, like, incremental repurchase. And my assumption is if M&A is considered, it'll probably be more bolt on things.
spk13: Yep. So, Elise, you
spk15: know, as we, you know, continuously evaluate our capital structure to ensure it's appropriate to take advantage of opportunities to deploy capital across share repurchases and organic and inorganic investment opportunities. So, you know, maintaining that flexibility is really important to us. And, you know, given where we were in the year and our cash position and the progress on the pre-cash flow, you know, wanted to take advantage of upping the repurchase target for the year. And maybe, Carl, you want to talk a little bit about...
spk02: Yeah. Thinking about this on a go-forward basis, Elise, I guess we've come a long way over the last three years, right? Since that beginning of that period, we've stabilized the business, we've rebuilt our talent base, we've restored our client base, and that's brought revenue growth to competitive levels. And at the same time, we've been able to return significant capital to shareholders while transforming and simplifying this company. And our allocation, the capital allocation, is also evolving. We're in a far better place from where we started, and through those efforts, we're now in a place to be able to execute and integrate organic opportunities. Across our industry, our peers have created value through M&A, and we believe M&A is a healthy component to a balanced approach to
spk15: growth. And we will continue to take a balanced approach to capital allocation and evaluate all of those options, which, to its worst, include share buybacks as a central component of that strategy.
spk06: Thank you. Our next question comes from Rob Cox of Goldman Sachs. Your line is now open.
spk01: Hey, thanks. Just following up on the organic growth questions, I mean, it appears that risking broking organic, excluding investment, income, and book settlements might have accelerated in the quarter. Can you talk about what continues to drive the strong performance there, and if you see anything that would lead you to believe growth would be materially different in the fourth quarter, as you head into kind of your largest revenue quarter there?
spk02: Yeah, I mean, we're really pleased with the 10% organic we did in R&B during the quarter, and, you know, the recognized house on top of a 10% comparable in the prior period last year. And neither book business or interest income meaningfully impacted that organic growth rate. We continue to expect meaningful contributions from our strategic investments and talent, we mentioned earlier, and platforms. And as we continue to pursue opportunities in line with our specialization strategy.
spk15: Yeah, and within, you know, CRB, the 10% growth rate is, as Carl alluded to earlier, really, you know, driven by new business. You know, both from the investments and talents that we've made in our, you know, existing talent base. Retention was obviously a component there as well, but really want to stress the importance of the new business that we've had the last quarter. Rate did not have a meaningful impact. Investment income did not have a meaningful impact, and the book of business activity did not have a meaningful impact. So really strong growth profile within CRB. Within ICT, there was 7% for the quarter that was really driven by the technology business, which had double digit growth. And, you know, as we mentioned, it was partially offset by tempered demand in the consulting business.
spk01: Okay, thank you. Appreciate that color. And then as my follow up, I was hoping you guys could comment on what type of, you know, magnitude of the tax shield you might be expecting from the sale of the TransAct business. And kind of secondly, sounds like the tax rate is actually getting better this year, but could you comment on if you're seeing any potential pressure into 2025, given some of the global regulatory changes on taxes?
spk15: Yeah, sure. So as it relates to TransAct, you will have noted that we have, you know, disclosed that there would be some impairment and other losses associated with that. For the most part, those are going to be capital losses, so they can only be applied to the extent that there are capital gains. And that is US specific, so we would have to have US specific capital gains to offset those. And in terms of tax rate going forward, not going to get into guidance at this point. We'll cover that on our full year call early next year. But, you know, we do, you know, seek to make sure that we've got appropriate structures in place to manage risks around increasing tax rates.
spk06: Thank you. Our next question is from Dr. Paul is from Mark Hughes of True Securities. Your line is now open.
spk04: Yeah, thank you. You talked about seeing better productivity from your new talent, and you've got a lot of capital that's available. Are you kind of redoing the this acceleration and hiring that you did a couple of years ago post the transaction? I mean, is that something that you're pursuing, or could you give us some sense of how that hiring pace has continued the last six, 12 months?
spk02: Yeah, so we're continuing to hire talent, Mark, but it's more opportunistically as we find people who are well aligned with what we're trying to
spk15: pursue
spk02: across our segments in terms of our business strategy. And I contrast that to a few years ago where we were really in rebuilding mode. You know, I think pretty much everyone on this call is well aware. We are rebuilt. That's great news. And it's showing up in the numbers, right? We're posting highly competitive growth rates. But, you know, there is talent out there that I think we can be an excellent partner to and will continue to seek out those individuals and bring them on and continue to grow this organization organically.
spk04: And then, Andrew, the transformation program, you've got some disclosures in the presentation, but the cash impact, the cash headwinds from that transformation program for full year 2024. Can you give us a sense of what that number is and then how much of that cash impact extends over into early 2025?
spk15: Yeah, sure. We expect the cash to be relatively consistent with prior years, but at the same time we'll have some cash outflows that bleed over into next year's from a timing perspective that will impact free cash flow and free cash flow margin as that plays out.
spk02: So
spk15: that'll sort
spk02: of wind its way out by, you know, the Q1 and H1. Thank you.
spk06: Our next question comes from Mike Zuremski of BMO. Your line is now open.
spk14: Hey, thanks. This is Charlie on from Mike. I guess this quarter we've heard from some carriers talking about increased competitiveness in the London market. Can you talk about what you're seeing there and how you see it or whether you see it impacting CRB and the globalized businesses?
spk02: Yeah, so it's a, I guess globally I'd say we're seeing a stabilizing to softening market and in the US and obviously the London markets, E&S are part of that. We're seeing the impacts of a slowdown in inflation. We're seeing commercial rates are starting to decrease, mostly in international countries and to a lesser extent in Europe and North America. Property rates are decreasing. Financial lines are decreasing. Cyber had a short-term stabilizing impact in the CrowdStrike event but quickly returned to
spk13: decreasing
spk02: rates. Casualty lines are stabilizing globally except for North America. And then I think we're still all working our way through the effect of Hurricane Milton and other NAPCAS. The results across our various global lines do vary. I mean, construction is stabilizing unless there are specific issues concerned with a particular project. Marine is stabilizing but marine liability is seeing high single digit increases. But in general, especially lines have been stable, which with a few exceptions like political risks and trade credit, which are reflecting the unsettled geopolitical environment. We just don't view a rate as a headwind or tailwind across the portfolio in terms of it's been impacting us the last several quarters. As we've said, our growth has been primarily driven by high retention rates and strong new business. And I think reflect the success of our specialization strategy that's going to really continue to differentiate us and help us make a difference.
spk14: Thanks. That's helpful. And I guess it sounds like you're going to keep including Transact in results until the sale closes. Is that the right way to think about it? And so should we expect to see it in your 4Q numbers? And how should we think about, I guess, 4Q margins looking depending on, I guess, to depend on when the deal closes? Yeah,
spk15: in terms of closing, we expect it to occur close enough to the end of the year that we would have essentially a full year of results within our numbers. So don't expect it to have an impact on the full year in terms of the guidance and range where we expect to land for the full year. And as we mentioned going forward, it will be the elimination of a headwind on organic growth margin and pre-cash flow margin.
spk06: Thank you. Our next question comes from Peter Newton of Evercore ISI. Your line is now open.
spk03: Hi, thank you. Good morning. Carl, you mentioned some optimism coming from a rebound in global M&A activity. I'm just wondering, could you give us some more color on what your team is seeing today that's causing that optimism? Thanks.
spk02: Yeah, I did use the word potential. So I'm not sure I'd phrase that as optimism, but I'd just phrase it as openness too. We have seen an uptick in result in M&A activity in Europe, less extended international. We've not seen that in North America.
spk03: Okay, got it. Yeah, thank you. That's helpful. And then for my second question on the continued tempered demand and consulting services, I'm just curious what the conversations with clients are like. Similarly, are you seeing any green shoots of this returning as well? And just any commentary on when you might expect this headwind to go away would be great. Thank you.
spk02: Okay, I think that comment you're referring to probably was regarding ICT over in the risk of broken. Do you want me to talk about HWC? I wasn't quite clear by the way you phrased it.
spk03: No, that was for ICT. Yeah, thank you.
spk02: Okay. Yeah, I mean, we are, you know, we're continuously strong demand for our technology solutions. And, you know, the way we built ICT over the years is that a lot of the consulting works its way around the technology. So it's helping clients maximize the value they get in that technology. So we, you know, when technology leads consulting will often follow. But there are some areas with an ICT that are can be sort of very cyclical and dependent on sort of various activity. Including M&A and securities issuance in conjunction with M&A by insurance companies. So, you know, we've been through these cycles before and we adjust to them, make sure that we can kind of keep the business pointed in the right direction. One of the things we've very successfully done over the last 10 or so years is actually changed the mix between consulting and technology to be far more balanced and about 50-50, which lowers the cyclicality of the business and makes it just a bit more resilient. That being said, some of the technology sales are recorded at the time of sale rather than spread over the life of the contract. So you get a little lumpiness in the results. You know, that smooths its way out between quarters, but you might have some lumpiness within quarters.
spk06: Thank you. Our next question comes from Meyer Shields of KBW. Your line is now open.
spk10: Hi, it's Jane from Meyer. Thank you for taking my question. My first question is on Cfans Act. Just wondering how would the removal of Cfans Act highly seasonal earnings pattern affect quality earnings going forward?
spk15: Yeah, so there's some information in the supplemental slides which we provided regarding the seasonality, which will allow a perspective on how that will impact us on a quarterly basis throughout the year.
spk10: Got it. My second question is what elements of your specialization strategy do you see as most critical in maintaining the strong client retention rate and less invoking?
spk02: Oh, so I point out a few things, right? One is that our specialization is set aside from others that our entire business, not just the parts that face the market, are structured along industry verticals. So these are businesses, not just practices. They have national or even global P&Ls with dedicated personnel directly responsible and accountable for that business. Every business operational financial decision is tied to that approach and that drives better outcomes for our clients because every person at every step in the process is focused on solving issues and providing products and services specific to that respective industry and geography. And as a result, we're able to tailor our solutions in a more focused manner and that delivers enhanced value through industry leading analytics and client engagement techniques. It makes for a very attractive proposition for clients looking to manage their risks. And as part of that strategy, we have local specialties in each of our regions because there are different nuances and different dynamics that depend on geography. For example, we've got industry verticals in real estate and hospitality and leisure in North America given large client based demand in that region. In Europe, where there's more of a demand for commercial auto insurance, we have local specialty teams for that particular segment. So it's all about the client and that works.
spk06: Thank you. Our next question comes from Alex Scott of Barclays. Your line is now open.
spk08: Good morning, everyone. This is Justin on for Alex. First question was related to the transformation program. It seems as though, you know, when we're looking at the savings, it's sort of coming like the savings are sort of coming to an end from a spending and a savings perspective. So just curious about your thoughts in terms of how we're thinking about how we should think about margins heading into 2025 in terms of the pace of margin expansion as sort of the transformation program sort of subsides over time.
spk15: We're not going to give any guidance on 2025 at this point. We'll talk about that early next year as we normally do. But we do expect some continued tailwinds from the transformation program in terms of fund rate savings generated this year converting to in-year savings through the early part of next year.
spk02: I'd also add that, you know, we've been quite explicit that we sized the transformation program and the associated savings by what we thought we could achieve during this three-year period, not the totals of margins improvement we thought we could get out of this organization. So we won't be done trying to drive margin and free cash flow margin improvement in subsequent years. We'll just be doing it as BAU rather than through a transformation
spk08: program. Got it. Thank you for the color there. I guess I just had a quick follow-up question just on high level on capital allocation. I think there was comments earlier about sort of infusion of capital coming in through sort of the notes on the Gallagher deal and sort of this transaction decision. When we're sort of and then sort of trying to triangulate that with sort of comments around, you know, being more opportunistic on hiring, purchases slightly being like, does that sort of lead some opportunities for inorganic growth? I'm just curious how you guys are thinking about capital allocation heading into 2025.
spk02: Yeah, I talked a little bit about our thinking on M&A
spk08: as part
spk02: of it. We've seen competitors create value through M&A and we think that opportunity is available to us as well now that we have gotten our house in simpler and better order through the transformation program. So if we can find, you know, a strategic opportunity that fits within our portfolio and helps us expand our reach across the value chains in which we operate, we will be interested. You know, we'll be looking for opportunities to improve our business mix to enhance operating in free cash flow margins. This is something I think we'll be talking about. I don't think. I know we'll be talking a
spk13: bit more
spk02: at
spk13: Investor Day.
spk05: Thank you. Our next question
spk06: comes from Katie Sackis of Autonomous Research. Your line is now open.
spk07: Okay, thank you. Good morning. I just wanted to ask about you guys' perspective on specifically middle markets. We've seen quite a bit of pickup in big name deal activity there and I'm curious what Willis's own strategy and approach towards the middle markets opportunity is. As we think about, you know, the next year ahead.
spk02: Well, I mean, we already operate in the middle market, so it's an area that, you know, we're familiar with. We see the attractive potential, a lot of job creation and business creation occurs in the middle market. And, you know, so it's not a new subject to us, I think, where I begin. We, you know, because a lot of economic creation occurs in the middle market, it's an attractive area to investor growth. And we've been doing that organically as part of our strategy over the past several years. And, you know, we've watched, for instance, our HWC businesses begin to repackage some of the intellectual capital that they've previously offered to large employers to service the middle market. And I think going forward, we'll continue to survey our opportunities, including inorganic opportunities as well as I alluded to in some of the earlier questions.
spk07: Thank you for the color. And then really quickly on TransAct, you know, it looks like the impact from the business on the group or enterprise level free cash flow margin is a little bit different from 2023 versus 2022. And thinking about, you know, the full year impact for this year, where would you guys say is the right place to contemplate that?
spk13: So, the headwind for
spk15: 2024 should be less than it has been historically, and that's largely driven by the intentional slowing of the growth there, which helps the free cash flow dynamic for that business. And then, you know, once it's no longer part of the business portfolio, next year, you know, we'll have a more meaningful impact in terms of accretion to the free cash flow margin.
spk10: Got it. Thank you.
spk06: Thank you. Our next question comes from Mark Marcon of Robert W. Baird. Your line is now open.
spk12: Thank you. Good morning. Nice results. I wonder if we can talk a little bit more about HWC in two respects. First of all, with regards to the health side, you've obviously, Carl, you've been through multiple election cycles. How do you think, you know, the healthcare consulting portion of the business is going to be impacted by the changes that could potentially happen one way or the other? On that part of the business?
spk02: Yeah, so, I mean, over this over a short-term period environment, Mark, you know, generally change or potential change is quite good for us. The consulting side, the clients have to sort of work their way through what the potential effect of changes in regulation might mean to their operation of their benefits programs. So, you know, I think generally we see a beneficial effect from change. And that's not just across our health business that can apply across our pension business and wealth or career business, you know, for instance, pay transparency. So, I think we've, you know, over prior cycles like this, you know, generally change is our friend.
spk12: That's my suspicion. And then going on to the wealth side and specifically with regards to pension, I'm sure you've seen all the news with regards to Boeing. And I'm just wondering, you know, to what extent that could end up, you know, spurring some actions on the pension side, particularly with regards to de-risking?
spk02: So, I mean, starting with Boeing, I mean, there's no question that traditional pension plans have played an important role in the financial security of millions and millions of people around the world. And, you know, the great shift we've had to define contributions, lots of unanswered questions. I think we're still seeing countries and employers trying to work their way through. And WTW is well positioned to help employers sort of to find out where they fit on that spectrum and to offer them the right solutions that are correct for their workforce. So, I think we welcome the debate over what's the right pension plan for our workforce. We've been answering that question for plan sponsors for a long, long, long time. With respect to the PRT outlook, I guess I'd say a few things. First of all, the current interest rate environment has been driving demand for pension de-risking strategies, where we assist our clients not just with the transaction, but also the evaluation and the analysis and the preparation that goes through it. This year we have seen more clients in North America take advantage of the favorable interest rate environment to initiate pension de-risking through bulk lump sums and alternate de-risking actions like annuity buyouts still remain attractive. We've been seeing these type of opportunities, especially in Great Britain. In general, given the on average well-funded nature of pension plans and the interest rate environment, we are seeing continued activity here. And we expect, as the bulk lump sum activity may fall off of it, we'll see increases in other areas such as annuity purchase or retiree medical de-risking activity. We'll probably talk a bit more about this as an investor.
spk06: Thank you. I am showing no further questions at this time. I would now like to turn it back to Carl for closing remarks.
spk02: Thank you. And thank you once again for joining us today. And I'd like to thank WGW's colleagues. Their dedication in supporting our clients has helped us to deliver another strong quarter and has us on track to achieve our goals for 2024. I'd also like to thank our shareholders for their continued support. We look forward to connecting with you all at our Investor Day in December. And Happy Halloween, everyone.
spk06: Thank you for your participation in today's conference. This does conclude the program. You may now disconnect.
Disclaimer